LEUPROLIDE for Prostate cancer: Side Effects & Safety Data
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
There are 45,399 adverse event reports in the FDA FAERS database where LEUPROLIDE was used for Prostate cancer.
Most Reported Side Effects for LEUPROLIDE
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Hot flush | 9,146 | 12.9% | 189 | 604 |
| Death | 8,772 | 12.4% | 8,757 | 739 |
| Intercepted product preparation error | 8,621 | 12.2% | 5 | 6 |
| Syringe issue | 7,847 | 11.1% | 9 | 12 |
| Device leakage | 5,861 | 8.3% | 7 | 8 |
| Wrong technique in product usage process | 5,062 | 7.1% | 6 | 14 |
| Fatigue | 4,805 | 6.8% | 223 | 631 |
| Injection site pain | 4,678 | 6.6% | 174 | 281 |
| Prostatic specific antigen increased | 2,432 | 3.4% | 225 | 297 |
| Asthenia | 2,176 | 3.1% | 216 | 578 |
| Off label use | 2,060 | 2.9% | 73 | 221 |
| Drug ineffective | 2,057 | 2.9% | 97 | 218 |
| Fall | 1,922 | 2.7% | 272 | 1,130 |
| Arthralgia | 1,756 | 2.5% | 66 | 225 |
| Prostate cancer | 1,736 | 2.5% | 836 | 306 |
Other Indications for LEUPROLIDE
Product used for unknown indication (10,600)
Endometriosis (4,494)
Precocious puberty (2,032)
Uterine leiomyoma (1,547)
Prostate cancer metastatic (1,109)
Bulbospinal muscular atrophy congenital (678)
Breast cancer (609)
Hormone-refractory prostate cancer (262)
Gender dysphoria (223)
Breast cancer female (191)
Other Drugs Used for Prostate cancer
ENZALUTAMIDE (25,954)
RELUGOLIX (18,752)
ABIRATERONE (12,209)
APALUTAMIDE (3,286)
GOSERELIN (2,080)
DEGARELIX (2,035)
BICALUTAMIDE (1,832)
SIPULEUCEL-T (1,720)
DENOSUMAB (1,627)
DOCETAXEL (1,551)